Biol stock forecast.

BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes. Experience the BIOLASE difference and discover the limitless potential of laser dentistry. Dentists.

Biol stock forecast. Things To Know About Biol stock forecast.

The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL. BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy …Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Find the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more.

High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year.Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.BIOLASE Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BIOLASE stock prices and determine the direction of BIOLASE's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading.

By John Blankenhorn, InvestorPlace Contributor Feb 17, 2023, 11:08 am EST. Biotech stocks fell hard in 2022, but they are poised for a comeback. Ginkgo Bioworks ( DNA ): Has a business model that ...1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.

Maybe one or two of three stocks will fail, but those small losses are irrelevant if and when the third stock has a 1,000% return. Here's why Ontrak ( OTRK 3.67%) , Nano-X Imaging ( NNOX 14.20% ...The current average BIOL price target, as estimated by these analysts, is $0.00. The predictions for the future BIOL stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for BIOL. Nov 21, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 21.38 . Today 200 Day Moving Average is the resistance level ( 15.93 $). Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.

Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ...

Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.24 per share, the total value of Biolase stock (market capitalization) is $2.85M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... The 3 analysts offering 1 year price forecasts for BIOL have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to BIOL in the past 3 months.The Ideanomics stock price gained 1.38% on the last trading day (Monday, 20th Nov 2023), rising from $2.18 to $2.21. During the last trading day the stock fluctuated 5.81% from a day low at $2.15 to a day high of $2.28. The price has risen in 6 of the last 10 days but is still down by -5.15% for this period. Volume has increased on the last day ...BIOL Stock. USD 0.08 0.0001 0.13%. BIOLASE stock price prediction is an act of determining the future value of BIOLASE shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of BIOLASE's future price could yield a significant profit.What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.Nov 30, 2023 · BIOL's stock price has decreased by -98.87% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 3 stock analysts, the average 12-month stock price forecast for BIOLASE stock is $113.33, which predicts an increase of 9,929.20%.

Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary. Jul 19, 2021 · Starting us off today is Twist Biosciences. In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis ... BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period. 3. Johnson & Johnson. There’s arguably no better bellwether in the healthcare sector than Johnson & Johnson, which is the biggest life sciences company in the world. J&J’s products include ...morningstar.com - November 1 at 12:25 PM. BIOLASE, Inc. (BIOL) ca.finance.yahoo.com - October 18 at 8:14 AM. BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. finance.yahoo.com - September 18 at 5:11 PM.

BIOL N/A N/A Short Interest (10/31/23) Shares Sold Short 8,569 Change from Last -70.26% Percent of Float 0.43% Stock Money Flow N/A Research & Ratings Biolase Inc. Per …

The 12-month stock price forecast is $113.33, which is an increase of 9,594.61% from the latest price. Price Target ( 9,594.61% upside) Analyst Consensus: …Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates. The average Bluebird Bio stock price prediction forecasts a potential upside of 96.45% from the current BLUE share price of $3.89. What is BLUE's forecast return on equity (ROE) for 2023-2026? (NASDAQ: BLUE) forecast ROE is N/A, which is considered weak.Nov 14, 2023 · BIOLASE stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for BIOLASE analysts is $ 22.25 . Today 200 Day Moving Average is the resistance level ( 17.28 $). Request PDF | Levine JM, D'Antonio CM. Forecasting biological invasions with increasing international trade. Conserv Biol ... Key message This study takes stock ...Penny Stocks To Buy [according to analysts]: Biolase Inc. Looking at the chart of Biolase Inc. (BIOL Stock Forecast), we can see a starkly different trend in comparison to the AMPE stock chart.Sure, this year has been relatively flat. But pull out a 2-year chart and you’ll see that BIOL stock has been in a perpetual downtrend since last …People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.

Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for BIOLASE stock is $113.33, which predicts an increase …

Hence, Semenkow has refined her 3L+ MM forecasts to reflect a more gradual launch in 2024. Even though these changes have resulted in a lower target price to $9 per share (a reduction of $2), she ...

Full Company Report for BIOL. View Biolase, Inc BIOL investment & stock information. Get the latest Biolase, Inc BIOL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.SYN Stock 12 Months Forecast. $4.00. (292.16% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Synthetic Biologics in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 292.16% change from the last price of $1.02.Oct 26, 2023 · Unraveling BIOLASE (BIOL) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing BIOLASE and its promising trajectory, we have meticulously collated insights from various analyst forecasts. BIOLASE is a company that develops and sells laser systems for dental procedures. The stock has a consensus rating of Buy …DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. BIOL Stock Analysis Overview What this means: InvestorsObserver gives Biolase Inc (BIOL) an overall rank of 34, which is below average. Biolase Inc is in the bottom half of …Jul 25, 2023 · Wood, a seasoned biotech investor, has gotten in front of this emerging trend by buying shares in several leading genomics companies. Among her various holdings in this high-growth area, Prime ... Find real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business.

2024 STOCK MARKET OUTLOOK. For the third quarter, ended Sept. 30, 2021, BIOL’s net revenue increased 45.8% year-over-year to $9.53 million. The company’s laser system sales increased 64% year-over-year, while its consumables and other revenue increased 21% year-over-year. However, its net loss came in at $3.28 million versus $12,000 in ...BIOL stock forecast Our latest prediction for Biolase Inc's stock price was made on the Nov. 30, 2021 when the stock price was at 0.44$. In the short term (2weeks), BIOL's stock price should outperform the market by 2.41%. During that period the price should oscillate between -11.17% and +18.16%.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.Instagram:https://instagram. bocelli's familyaapl rsifutures proprietary trading firmsstock practice app BIOLASE Stock Earnings. The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next ...The Biolase Inc ( BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1639.46% increase from … most valuable mercury dimes p 500 all time high 3. Johnson & Johnson. There’s arguably no better bellwether in the healthcare sector than Johnson & Johnson, which is the biggest life sciences company in the world. J&J’s products include ... alexandria real estate stock Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.BIOL Stock 12 Months Forecast. $22.00. (1659.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average …